Epilepsy is one of the most common neurological diseases, imposing a heavy burden on patients and society, with about 70 million people estimated to be affected worldwide [1]. More significantly, in 30% of the patients, epilepsy is drug-resistant and cannot be effectively controlled by antiepileptic drugs (AEDs) [2]. For such patients, surgical intervention is the main therapeutic option, and about 60% of the patients with drug-resistant focal epilepsy become seizure-free after resective epilepsy surgery [3].
20
MAR
MAR
0